Beta Bionics, Inc. Common Stock
BBNX
$18.98-2.22%
End of day · as of Sep 30, 2026, 8:15 PM ET
Mkt cap
$640.80M
EV/Sales
6.08
P/E ratio
N/A
FY2025 Revenue
$100.25M
EPS (TTM)
$-1.60
Gross Margin (FY2025)
55.40%
Profit Margin (FY2025)
-73.02%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Use this BBNX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BBNX income, balance, and cash tables.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company in the Healthcare sector.
Latest cached Beta Bionics, Inc. Common Stock (BBNX) revenue for Dec 31, 2025 was $100.3M. Net income was -$73.2M. Statements: https://lician.com/financials/bbnx
Beta Bionics, Inc. Common Stock (BBNX) market capitalization is $640.8M on the latest cached snapshot.
Beta Bionics, Inc. Common Stock (BBNX) cached previous close $19.41; day range $18.45 – $19.52; volume 1,455,859. Session quote: https://lician.com/quote/bbnx
Beta Bionics, Inc. Common Stock (BBNX) latest cached earnings event is "BBNX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BBNX filing is 8-K · Sep 17, 2026. Filings: https://lician.com/sec/bbnx